Sweden Special Situations

Image Systems AB (IS.ST) is conducting a preferential rights issue to raise SEK 21.4 million (~$2.3M).

Realfiction Holding AB (REALFI.ST) intends to launch a rights issue of units comprising shares and series TO3 warrants to raise up to SEK 36 million (~$3.8M), subject to approval of an Articles of Association amendment…

Cell Impact AB (publ) (CI.ST) is conducting a rights issue of units to raise approximately SEK 53.6 million (~$5.7M) to repay bridge financing and accrued interest.

Subscriptions were made by CEO Daniel Vallin, CFO Malin Lundberg, CHRO Karina Sick Larsson, Chairman Mats Boquist, and board members Jan Pieters, Mats Franzen and Lars Bergström.

Biosergen (BIOS.ST) is launching a SEK 40 million (~$4.2M) rights issue to raise capital.

Subscription period runs August 6–20, 2026; unit rights trade August 6–17, 2026. Terms: 3 unit rights subscribe for 1 unit; each unit contains 6 shares, 2 TO5 warrants, and 2 TO6 warrants. Subscription price is SEK 0.330 per unit, equivalent to SEK 0.055 per share. Fully subscribed proceeds are approximately SEK 53.6 million (~$5.7M) before issue costs and bridge loan repayment. The subscription period runs from August 6 to August 20, 2026, with a subscription price of SEK 0.330 per unit, or SEK 0.055 per share.

SpectraCure expanded the guarantee level in its ongoing rights issue to approximately 75 percent through a top guarantee commitment. Vator Securities AB is the top guarantor, as well as the previous bottom guarantor. The guarantee compensation is 2 percent of the guaranteed amount in cash and 20 percent through set-off against newly issued units.

Precise Biometrics (PREC.ST) is conducting a rights issue to finance the integration of a merger with Fingerprint Cards. The subscription period for the issue runs from July 29 to August 12, 2026. Proceeds are intended to realize synergies and invest in growth areas for the combined hardware and software entity. An investor presentation is scheduled for August 6, 2026, to discuss the merger and the financing. The rights issue creates a near-term actionable window ending August 12, with the August 6 presentation potentially revealing deal terms or synergy details.

S2Medical AB (publ) (S2M.ST) restructured its rights issue into units to accommodate Euroclear Sweden's two-decimal processing system. The revised record date is 20 August 2026, with the subscription period running from 24 August to 10 September 2026. Only B-unit rights and paid subscribed B-units will trade on Nasdaq First North Growth Market.

Scandi Standard AB (publ) (SCST.ST) has announced a proposed rights issue of approximately SEK 408 million to finance its acquisition of Glenhaven Foods. Completion is subject to approval by an extraordinary general meeting on August 26, 2026. The issuer proposes 3,268,143 new ordinary shares at SEK 125 per share; the subscription period is September 1–15 after the August 28 record date. Shareholders receive one subscription right per existing share, with 20 rights required for one new share. A shareholder group controlling approximately 63% has committed to subscribe pro rata and, subject to EGM approval of the underwriting fee, conditionally underwrite the remaining approximately 37%. Rights trade September 1–10; the 2.8% TERP discount is based on the July 29 closing price of SEK 128.80. The backstop reduces subscription shortfall risk but does not remove the EGM approval condition.

Precise Biometrics (PREC.ST) is launching a rights issue to raise approximately SEK 110 million (~$12M) to finance integration following its merger with Fingerprint Cards and realize identified synergies. The subscription period runs from July 29 to August 12, 2026. Guarantee commitments totaling SEK 100 million (~$11M) include DNB Bank ASA and Schonfeld Global Master Fund LP.

Sweden Buyersclub AB (BUY.ST) published a preliminary timetable for its rights issue: the record date was July 27, 2026; the subscription period was set for July 29 to August 12; subscription rights trading was set for July 29 to August 7; and the outcome was expected on August 14. The source notes that some dates may change.

Clean Motion AB (CLEMO.ST) announced final results for a rights issue of up to 198,919,700 units at SEK 0.10 per unit: 49.2% was subscribed and guarantee commitments for 41,409,914 units, or 20.8% of the issue, will be used. The issue adds 139,243,790 shares and is expected to provide approximately SEK 10.0 million before costs after a SEK 4.0 million loan set-off. Non-participating shareholders face approximately 41.1% dilution; full exercise of TO4 could add up to another 29.2% dilution, with exercise from January 18 to February 1, 2027 and a maximum exercise price of SEK 0.12.

4C Group AB (4C.ST) raised approximately SEK 73.6 million (~$7.6M) through a rights issue and over-allotment to fund general corporate purposes and set off SEK 13.7 million (~$1.4M) in shareholder loans. The rights issue for 7,654,999 shares at SEK 7.00 per share was approximately 240% oversubscribed, while the board exercised an over-allotment option to issue 2,857,142 shares at SEK 7.00 to Salénia AB and Fredrik Lundgren for SEK 20 million (~$2.1M). Combined, the transactions result in a total dilution effect of approximately 21.5%. New shares are expected to commence trading around 2026-08-17. The over-allotment was exercised via directed placement to two committed investors rather than pro-rata to all applicants, creating potential inequality-of-treatment questions.

Nicoccino Holding AB (NICO.ST) is launching a rights offering to raise approximately 17 MSEK to strengthen working capital and finance growth. The subscription period runs from July 24 to August 21, 2026, and trading in subscription rights begins July 27. Because the offering is unbackstopped, the ~44.63% of shareholders who have waived their subscription rights creates a structural shortfall risk. The 1.10 SEK subscription price provides a reference floor as it matches the recent set-off issue price.

Precise Biometrics resolved on a SEK 110 million (~$11M) rights issue. The stock began trading ex-rights on Nasdaq Stockholm on July 24, 2026. The rights issue follows the completion of the merger with Fingerprint Cards AB.

Alligator Bioscience AB (ATORX.ST) is launching a rights issue for SEK 125.6 million (~$13M) to fund a strategic pivot away from the independent development of mitazalimab. The offer is priced at SEK 0.04 per unit, comprising two ordinary shares and two warrants, resulting in approximately 90.9% dilution for non-participants. Subscription undertakings and guarantee commitments cover 47% of the issue. The board resolution is subject to EGM approval on 26 August 2026, with a subscription period from 4 to 18 September 2026. The deeply discounted price and high uncovered portion of the issue create a high-risk restructuring dynamic.

Precise Biometrics AB (PREC.ST) is launching a rights issue to raise SEK 110.3 million (~$11M) to fund post-merger integration and repay bridge financing. The company is offering 134,508,376 new shares at SEK 0.82 per share. The record date is 27 July 2026, and the subscription period runs from 29 July to 12 August 2026. Guarantee commitments cover approximately 91% of the issue. The offer is priced at a 35% discount to TERP, and non-participating shareholders face approximately 48% dilution.

SpectraCure (publ) is conducting a partially secured rights issue to raise capital. The offering consists of 1,141,205,688 units, with subscriptions ending August 4, 2026. This event serves as the next catalyst for the company.

Clean Motion AB has secured subscription commitments from its lenders for a current rights issue. The commitments are provided via the offsetting of claims against the company. No compensation is being paid for these commitments. This arrangement creates conditions for a positive outcome in the rights issue.

Vetted Assets AB (publ) (VETT.ST) entered a conditional agreement to acquire 70% of Criss Bellini AB for a preliminary SEK 25 million cash price, subject to financing and customary conditions. The board resolved, subject to approval at an August 19, 2026 extraordinary general meeting, on an approximately SEK 15 million rights issue at SEK 4.40 per share. The August 24 record date gives one right per existing share, and 17 rights subscribe for one new share; the subscription period is expected to run August 26-September 9. Larger shareholders and senior executives provided approximately SEK 15.04 million of subscription undertakings, covering 100% of the base issue but excluding the potential SEK 10 million over-allotment. Those undertakings are unsecured by bank guarantee, blocked funds, pledge or similar arrangements and therefore do not eliminate execution risk. Resurs Bank issued a conditional SEK 20 million credit decision at 8.90% annual interest. The company states that the acquisition implies approximately 3.9x EV/2025 EBIT, based on Criss Bellini's SEK 8.5 million EBIT.

A biotech company developing treatments for Parkinson's and CNS disorders, IRLAB Therapeutics AB (IRLAB-A.ST), has completed the registration of its rights issue with the Swedish Companies Registration Office. The last day for trading BTAs on Nasdaq Stockholm is 15 July 2026, with the record date for BTA conversion set for 17 July 2026. New shares are expected to be booked on 21 July 2026. This fixed timeline removes uncertainty on share delivery and creates a short conversion window for BTA holders. Investors should monitor for residual arbitrage between BTAs and ordinaries ahead of 15 July.

Prostatype Genomics AB (PROGEN.ST) launched a rights issue of units for gross proceeds of up to approximately SEK47.4 million. Each SEK0.80 unit contains eight shares, two TO6 warrants and four TO7 warrants, implying SEK0.10 per share, and the subscription period runs from July 9 through July 23, 2026. Subscription commitments plus bottom and top-down underwriting total approximately SEK43.2 million, or 91.3% of the maximum issue; Vator Securities AB is the underwriter, not a strategic buyer. Proceeds are intended for the U.S. Medicare reimbursement process, commercialization in the United States and Europe, working capital and specified liabilities. Non-participating holders face up to approximately 88.9% dilution from the initial eight-for-one share issuance. TO7 has an event-driven exercise window linked to a Medicare approval announcement, with a December backstop window if approval has not been announced.

Clean Motion AB (CLEMO.ST) is conducting a rights issue of up to 198,919,700 units for gross proceeds of up to approximately SEK19.9 million. Each SEK0.10 unit consists of one new share and one free TO4 warrant. The subscription period runs from July 9 through July 23, 2026. Each TO4 warrant may be exercised from January 18 through February 1, 2027 at 70% of the January 4-15 VWAP, subject to a SEK0.10 floor and SEK0.12 cap. The issue will not proceed unless subscriptions reach at least 119,351,820 units, equal to 60% of the offer. The SEK0.10 subscription price was close to the contemporaneous market price of approximately SEK0.09-SEK0.10, not deeply discounted to SEK0.242842.

A company, 4C Group AB (4C.ST), a provider of software and services for military training, crisis management, and organizational resilience, launched a fully secured SEK 54 million (~$5.6M) rights issue. Existing shareholders can subscribe to one new share for every five shares held at a price of SEK 7.00 per share. The subscription period runs from 9 July to 23 July 2026, with a maximum of 7,654,999 new shares to be issued. The board may also exercise an over-allotment option of up to approximately SEK 20 million (~$2.1M) for 2,857,142 additional shares. The short subscription window and the over-allotment option create a near-term arb for holders deciding whether to exercise or sell subscription rights.

The Swedish e-commerce platform and membership club Sweden BuyersClub AB (BUY.ST) is launching a SEK 30M (~$3M) rights issue to fund a pivot toward an active M&A strategy. The company is offering up to 4,955,369 new shares at SEK 6.05 per share, compared to a last price of SEK 4.68. Existing shareholders and external investor Elcykelpunkten Stockholm AB have provided subscription commitments covering 80% of the issue. Under the 3:10 ratio, ten subscription rights entitle holders to three new shares, with the subscription period scheduled for July 29 through August 12, 2026. Proceeds are allocated toward acquisitions, logistics expansion, and working capital. The Extraordinary General Meeting on July 23 serves as the primary gating item for the recapitalization and subsequent acquisition agenda.

A Swedish SaaS provider (SpectrumOne AB, SPEONE.ST) finalized the timetable for a guaranteed subsidiary rights offering and a discounted warrant issue to advance the planned separate listing of its Cloud Explorers unit. The subsidiary offering seeks to raise SEK 12.4 million (~$1M) through the sale of 51,777,613 shares at SEK 0.24 each, with a record date of July 10, 2026, and a subscription period running July 14–28. Simultaneously, the company will launch a TO5 warrant rights issue on July 6, 2026, offering holders the right to subscribe for shares in May 2027 at 70% of the volume-weighted average price. The Cloud Explorers offering provides shareholders a direct stake in the subsidiary ahead of its planned spin-out, while the TO5 warrants offer a long-dated equity option with a SEK 0.10 floor and a SEK 0.54 cap.

The board of Iberian Yield Investment AB (IBY.ST), a Swedish public company, extended the subscription period for its rights issue to September 15, 2026, signaling weak initial demand for the capital raise. The offering was originally authorized on March 19, 2026, and all other terms of the issuance remain unchanged. This extension grants existing shareholders and external investors additional time to participate in the offering. The extension signals weak initial demand and provides the market more time to evaluate participation before the final results are published after the September deadline.

The diagnostic developer Prostatype Genomics AB (PROGEN.ST) has launched a SEK 47.4 million (~$5M) rights issue of units priced at a 30% discount to its theoretical ex-rights price to fund Medicare reimbursement and commercialization. Each SEK 0.80 unit comprises eight shares and six free-of-charge warrants, with the offering 70% covered by subscription and underwriting commitments from Vator Securities AB and other investors. Approximately SEK 7.4 million (~$767.4K) of these commitments will be settled via the set-off of existing shareholder loans. The record date is set for July 7, 2026, following the last cum-rights trading day on July 3, with the subscription period closing on July 23. The deeply discounted units and warrants create a tradable subscription-rights window while presenting non-participating shareholders with approximately 88.9% dilution.

The board of Clean Motion AB (CLEMO.ST), a developer of lightweight electric vehicles for last-mile delivery, launched a SEK 19.9 million (~$2M) rights issue of units to fund working capital and sales expansion. The offering consists of up to 198,919,700 units priced at SEK 0.10, where each unit contains one new share and one series TO4 warrant. Shareholders as of the July 7, 2026 record date will receive one unit right per existing share, with the company potentially raising an additional SEK 5.0 million (~$518.5K) through an overallotment option. Insiders, including the chairman and executives, have indicated non-binding intentions to subscribe for SEK 2.5 million (~$259.3K), representing approximately 12.6% of the issue. The offering is contingent on a 60% minimum subscription level of 119,351,820 units, and the inclusion of free warrants creates a potential dilution overhang and a new tradable instrument.

A strategic partner (Flerie AB) has backstopped a SEK 39.9 million (~$4M) rights issue for Biosergen AB (BIOSGN-BTU.ST), a Swedish life science developer of drug candidate BSG005, as a mandatory condition for a planned merger. The offering of 79,839,888 shares at SEK 0.50 per share entitles holders to 34 new shares for every one held, resulting in approximately 97.1% dilution for non-participating investors. Flerie Invest AB and other parties have provided 100% coverage through SEK 18.5 million (~$2M) in subscription undertakings and SEK 21.4 million (~$2M) in guarantee undertakings. If the guarantee is fully called, Flerie could obtain up to 46% of the total votes, requiring a mandatory bid exemption from the Swedish Securities Council to bypass the 30% ownership threshold. The record date is August 10, 2026, with the subscription period running from August 12 to August 26. The extraordinary general meeting scheduled for August 6 serves as the primary gating event for both the dilutive financing and the integrated merger plan.

Spotr Group AB (SPOTR.ST), a Swedish investment company holding a 3.2% stake in White Pearl Technology Group AB, is launching a SEK 4.8 million rights issue primarily to settle debt ahead of a potential spin-off and strategic transaction deadline. The offering comprises 536,568 new shares at SEK 9 per share, with eight subscription rights required to subscribe for three new shares. The subscription period runs from June 30 to July 14, 2026. Approximately SEK 3.6 million of proceeds will be settled by set-off of existing loans and interest, leaving about SEK 1.3 million in new cash. Following the issue, the board intends to call an extraordinary general meeting to distribute the White Pearl stake to shareholders. The raise bridges the company toward an August 24, 2026 deadline to complete a reverse acquisition, failing which it may initiate a delisting.

Qbim Aktiebolag (QBIM.ST), a Swedish provider of AI-driven cloud services for sales organizations, published an information memorandum for its previously announced rights issue to fund product development and international expansion. Proceeds are intended for Q-Sales 2.0, the Q-Meet assistant, English-language platform rollout, Norwegian expansion and working capital, with Bergs Securities AB acting as advisor. The rights issue had been announced at approximately SEK 6.1 million, priced at SEK 0.28 per share, with subscription running from June 23 to July 7, 2026. The remaining disclosure gap is not price or size but whether the offering is backstopped.

A private investor group (Flerie Invest) is backstopping a SEK 39.9 million rights issue for Biosergen AB (BIOSGN.ST), a Swedish biotech developing the drug BSG005, to fund the company's merger and restart clinical programs. The offering of approximately 79.8 million shares is priced at SEK 0.50, a sharp discount to the SEK 7.50 market price, and entitles holders to 34 new shares for every one held. The transaction is 100% covered by SEK 18.5 million in subscription undertakings and SEK 21.4 million in guarantees from Flerie Invest, Tuvedalen Limited, and Christian Horsdal. Shareholder approval is sought at an August 6, 2026, extraordinary general meeting, with the subscription period scheduled to run from August 12 to August 26. The deeply discounted terms create approximately 97.1% dilution for non-participants, and Flerie Invest’s potential 46% ownership post-issue will require a mandatory-bid exemption from the Swedish Securities Council.

The medical equipment developer ScandiDos AB (SDOS.ST) is launching a SEK 12.8 million preferential rights issue to fund the launch of its Delta4 SRS Pro radiation-therapy quality-assurance system. The company is offering up to 14,252,771 new shares at SEK 0.90 per share; existing shareholders receive one subscription right for each existing share, and four subscription rights are required to subscribe for one new share. Larger shareholders and the CEO have provided subscription commitments totaling just over SEK 4.3 million, or 34% of the offering. Net proceeds of about SEK 12.3 million after costs are intended for sales and marketing, working capital and regulatory costs. Trading in subscription rights on Nasdaq First North runs from June 23 to July 6, 2026, with the outcome expected on July 10, 2026 or as soon as possible after the subscription period ends.

Larger shareholders and board members have provided subscription undertakings covering 75% of OrganoClick AB's (ORGC.ST) SEK 39.6 million rights issue, providing a largely covered but not fully underwritten capital raise for the sustainable fiber and biopolymer chemical products company. The company is offering up to 88,002,412 new shares at SEK 0.45 per share, representing a 15% discount to the 10-day volume-weighted average price. Existing holders receive four subscription rights for every share held as of the June 23 record date, and five rights entitle the holder to subscribe for one new share. The subscription period is scheduled to run from June 25, 2026 through July 9, 2026 following publication of the information memorandum. Advokatfirman Delphi and Eminova Fondkommission are advising on the transaction.

The board of the Nordic security services provider Nordic LEVEL Group AB (LEVEL.ST) opened the subscription period for its SEK 45 million rights issue today, a capital raise that introduces significant dilution risk for the micro-cap entity. The offering consists of up to 140,125,104 shares, with trading in subscription rights running through July 2, 2026, and the overall subscription period closing July 7, 2026. The company maintains an over-allotment option that could increase the total issue by up to SEK 10 million if oversubscribed. DNB Carnegie Investment Bank AB is serving as the sole global coordinator and bookrunner. The outcome of the Swedish rights issue is expected around July 8, 2026, which will determine the final impact of the potential SEK 10 million in additional dilution.

The board of Bong AB (BONG.ST), a European specialty packaging and envelope company, initiated a SEK 63.4 million preferential rights issue priced at SEK 0.30 per share to optimize its capital structure and provide strategic flexibility. The offering of 211,205,058 new shares is 100% guaranteed through SEK 24.8 million in subscription commitments and SEK 38.6 million in underwriting guarantees. Shareholders on the record date of July 1, 2026, will receive one subscription right per existing share, with the subscription period running from July 3 to July 17, 2026. The transaction results in a 50% maximum dilution and remains conditional on regulatory approval of a share capital reduction by June 29, 2026. Subscription rights will trade on Nasdaq Stockholm from July 3 to July 14, 2026, creating an actionable entitlement window ahead of the expected July 17 close.

Shareholders approved an actionable rights issue for 4C Group AB (4C.ST), an organizational readiness and training management software provider, at SEK 7.00 per share. The transaction involves the issuance of up to 7,654,999 shares with preferential rights for existing shareholders to raise gross proceeds of approximately SEK 53.6 million. The board is also authorized to issue up to 2,857,142 additional shares via an over-allotment option to raise approximately SEK 20 million more. Today's extraordinary general meeting approval fixes the subscription price and maximum base proceeds, with the over-allotment option adding up to 2,857,142 shares, or about 37% of the base issuance, if exercised.

The global appliance company Electrolux Group (ELUX-B.ST) is launching a SEK 9.1 billion fully underwritten rights issue to recapitalize its balance sheet and fund growth initiatives. Supported by largest shareholder Investor AB, the $936 million offering is underwritten by Morgan Stanley, SEB, and Deutsche Bank. Proceeds are intended to finance profitable growth, expedite the achievement of financial targets, and strengthen the balance sheet. The naming of the underwriting syndicate removes execution risk for the recapitalization of this Swedish large-cap, leaving the subscription discount and timetable as the next key details to watch.

A Swedish developer of professional LED lighting products, Lightning Group AB (LIGR.ST), is acquiring a peer for a nominal SEK 1 plus earn-outs in a deal financed by a fully guaranteed SEK 22.7m rights issue. The acquisition of Aura Light includes performance-based consideration equal to 60% of the target's EBITDA through June 2029 for a business that generated SEK 280m in 2025 revenue. The financing is fully backed by SEK 17.6m in subscription commitments and SEK 5.1m in underwriting from major shareholders and the CEO. The subscription price will be set on July 28 at a 20% discount to the 10-day VWAP, subject to a SEK 0.50 floor. Key dates include a last cum-rights trading day of August 3 and a subscription window from August 7 to August 21 ahead of an expected August 31 closing. The guaranteed rights issue at a 20% discount creates a tradable subscription-rights window for a micro-cap consolidator executing a transaction that quadruples group revenue.

Annexin Pharmaceuticals AB (ANNX.ST), a Swedish biotech company focused on cardiovascular and cancer treatments based on the annexin A5 protein, opened a SEK 20 million rights issue today to secure expansion capital. The offer is priced at SEK 12.00 per share with a subscription ratio of 6 new shares for every 25 rights held. Subscription rights began trading today and will continue through June 29, 2026, ahead of the July 2 subscription deadline. The issue is 60% secured via SEK 12 million in commitments from board members, management, and existing shareholders, with an overallotment option of up to 416,670 additional shares available if oversubscribed. The transaction creates a short-duration arbitrage opportunity for existing holders due to the renunciation window and the discount to pre-announcement prices, with outcome results expected on July 3.

The Swedish infrastructure services company Netel Holding AB (NETEL.ST) announced a SEK 127 million fully secured rights issue to refinance debt and facilitate its pending merger with Infrea AB. The 3:4 offering is priced at SEK 3.50 per share, a 1% discount to the theoretical ex-rights price, with an overallotment option potentially increasing total proceeds to SEK 202 million. The issue is fully backstopped by existing shareholders, led by Etemad Group AB, and new investors including Infrea shareholders. Non-participating shareholders face potential dilution of up to 43%, or 54% if the overallotment is fully utilized. The August 2026 extraordinary general meeting creates a binary catalyst for the name, as shareholders must vote to approve both the rights issue and the merger. While the near-zero discount to the theoretical ex-rights price limits arbitrage spread, the tradable rights provide a clean exit mechanism for non-participants.

AlzeCure Pharma (ALZCUR.ST) began the subscription period for a SEK 30.1 million rights issue to fund its clinical-stage CNS drug pipeline. Each existing share held on the June 12 record date carries one subscription right, and five rights entitle the holder to subscribe for one new share at SEK 1.31; the subscription period runs from June 16 to June 30, 2026, with subscription-rights trading planned through June 25. Subscription undertakings from major shareholders, the board, management, and other large holders cover about SEK 9.3 million, or 31% of the issue, and the two largest shareholders, BWG Invest Sarl and Sjuenda Holding AB, have undertaken to subscribe for any remaining shares so the issue is described as 100% secured. Those undertakings are not secured by bank guarantee, blocked funds, pledge, or similar arrangements, so the backstop reduces but does not eliminate execution risk for non-participating holders.

A streaming software provider (Mavshack AB, MAV.ST) launched a deeply discounted SEK 8M preferential rights issue that forces shareholders to either subscribe or face severe dilution while its stock remains halted. The company is offering 1,599,871,800 shares at SEK 0.005 per share, with one existing share receiving one unit right to subscribe for a two-share unit at SEK 0.01. Following a revised timetable, the subscription period will run from June 26 through July 10, 2026, with the record date set for June 24. Because Mavshack is currently halted on the Nasdaq First North Growth Market, unit rights and paid subscribed units will not be available for trading. Shareholders must commit to the rescue financing by the July 10 deadline or face significant dilution without the ability to realize value from their rights on the secondary market.

Qbim Aktiebolag (QBIM.ST) announced a fully backstopped rights issue to raise SEK 6.1M (~$646.4K) through the issuance of 21,881,845 shares at SEK 0.28 per share. The offering is 100% covered by 39.8% in subscription commitments from insiders and major holders, while SpectrumOne AB serves as the sole guarantor for the remaining portion without receiving a fee. Three rights plus SEK 0.84 enable the purchase of one new share, representing a maximum dilution of 25.0% for non-participants. The record date is June 18, 2026, with a subscription period from June 23 to July 7 and rights trading on Nasdaq First North scheduled for June 23 through July 2. Proceeds will fund AI product development, Norwegian expansion, and working capital requirements. The transaction creates a short arbitrage window for existing holders as rights trade from June 23 to July 2, with a theoretical ex-rights price of approximately SEK 0.21 at current levels and an unusual no-fee guarantee structure.

The Extraordinary General Meeting approved the issuance of up to 119,585,679 Netel shares as merger consideration.

Andreas Morfiadakis appointed CEO of SBB, effective 10 August 2026.

Netel Holding AB (NETEL.ST) and Infrea AB are proceeding with a statutory merger after receiving all required regulatory approvals. The Swedish Competition Authority cleared the merger, and the Inspectorate of Strategic Products issued a no-action decision on the FDI screening notification. Completion remains conditional upon other requirements set out in a June 15, 2026 press release. Regulatory clearance removes the last external gating risk, leaving the merger dependent only on internal conditions and shareholder votes.

Infrea is merging with Netel Holding AB (NETEL.ST), with Netel acting as the absorbing entity. The combined company is expected to have annual revenue of approximately SEK 5 billion and more than 1,200 employees. Netel plans a fully secured rights issue of approximately SEK 127 million, comprising about SEK 99 million from existing shareholders and SEK 28 million from new investors, including certain major Infrea shareholders, with an optional overallotment issue of up to SEK 75 million. Infrea CEO Martin Reinholdsson will become CEO of the combined group. Extraordinary general meetings are planned for August 2026, and registration of the merger is expected in the fourth quarter of 2026.

A strategic buyer, Eastnine AB (publ) (EAST.ST), a Swedish real estate company focused on modern office properties, has signed an agreement to acquire the 40-story office property. The Bridge in Warsaw from Ghelamco for a preliminary purchase price of approximately €260M (~$297M). The property is 92% leased with an annual rental value of €18.2M (~$21M) and average lease terms exceeding ten years. The transaction is conditional on financing and expected to close in Q4 2026. Funding includes existing cash, a €180M (~$206M) secured bank loan from Erste Group, and property refinancing, requiring no equity issuance. This acquisition doubles Eastnine's market position in Warsaw and is projected to increase management earnings per share by 201% to €0.371.

Silex Microsystems AB (SILEX.ST), a pure-play MEMS foundry, entered a definitive agreement to acquire onsemi's 200 mm integrated-circuit fab in Mountain Top, Pennsylvania, for $40 million. The asset purchase includes the production facility, real property, infrastructure, and manufacturing equipment. Silex plans to convert the site into a MEMS fab with estimated capital expenditure of approximately SEK 1.6 billion (~$166 million). Closing is expected around year-end 2027, subject to customary conditions, including CFIUS clearance.

Genova Property Group AB (GPG.ST), a Swedish real estate company, agreed to acquire an eight-property Stockholm portfolio from Landia and Landera for SEK 673 million (~$70M). The acquisition is funded via bank loans, cash, and SEK ~124 million through repurchased shares and a new share issue to Landia at SEK 76.72 per share. This issuance will increase Landia's stake from 2.8% to approximately 6.2% and includes a 12-month lock-up. The deal is expected to close on September 1, 2026. The acquisition is expected to increase management result per share by approximately 15% while limiting dilution by issuing shares at NAV.

A Swedish-listed consolidator, Calviks AB (CALVIK.ST), signed a share purchase agreement to acquire a 51% stake in Batne AS, a recruitment, staffing, and management-for-hire company. The initial purchase price is approximately 6.9 MNOK on a debt-free basis and will be paid in cash at closing. Batne AS serves the Telemark and Vestfold regions and is projected to generate roughly 35 MNOK in revenue and 3 MNOK in EBIT during 2026. While the economic transfer date was May 1, 2026, legal closing is expected in summer 2026 subject to seller administrative conditions. This bolt-on acquisition leaves a minority interest and a potential path to full ownership for Calviks following the summer close.

The board of Episurf Medical AB (EPIS-B.ST), a Swedish firm with real estate and medtech operations, authorized a 2,888,888,888-share issuance causing 29.42% dilution to settle part of an acquisition transforming the company. The issuance to KlaraBo Empire Top Holding AB at SEK 0.045 per share offsets a MSEK 130 promissory note, representing partial consideration for the MSEK 361 total purchase price of the KlaraBo property portfolio. A supplementary agreement has deferred the second partial completion of the transaction until no later than December 30, 2027. This equity issuance crystallizes substantial dilution for existing shareholders and creates a long-dated completion tail for a deal that is fundamentally transforming the company into a Nordic real estate vehicle.

A Nordic e-commerce operator, Online Brands Nordic AB (publ) (OBAB.ST), agreed to acquire the clothing designer and online retailer Frank Dandy AB for an initial SEK 43.2M to add a profitable brand to its regional portfolio. The acquisition from Frank Dandy Holding AB includes a cash payment subject to net debt adjustments plus potential earn-outs of SEK 10M in 2026 and SEK 6M in 2027. Frank Dandy generated SEK 15.8M in EBITA on SEK 120M in sales for the period from Q2 2025 through Q1 2026, bringing the buyer’s pro forma annualized sales to SEK 637M. Closing is expected on July 1, 2026, subject to customary conditions. The bolt-on acquisition adds a high-margin brand with a 13% EBITA margin and fits the buyer's stated strategy of acquiring Nordic e-commerce companies.

A Swedish real estate company secured debt financing for its property portfolio acquisition - SEK 897 mn - clearing the final condition for Episurf Medical AB (publ) (EPIS-B.ST) to complete the transaction. Episurf Medical AB (publ) (EPIS-B.ST), a Swedish real estate company acquiring and managing Nordic properties, is acquiring the assets from KlaraBo Empire Holding AB in a $92M deal expected to close on July 2, 2026. The new credit facility is priced at STIBOR plus 225 basis points, while consideration includes B-shares and a vendor loan note. One property valued at approximately SEK 233 mn will have its legal closing deferred for up to 18 months. Shareholders previously approved the acquisition at an EGM on April 13, 2026. This financing agreement removes the final pre-close uncertainty and triggers the share issuance to the seller upon closing, creating a near-term dilution event for existing shareholders.

A life science investment company, Flerie AB (FLERIE.ST), is acquiring the distressed Swedish biotech Biosergen AB in a SEK 54.7 million statutory merger that marks Flerie's first investment since its listing. The board-approved plan uses an exchange ratio of 31 Biosergen shares for each new Flerie share, implying a value of SEK 0.67 per share and a 33% premium. To provide bridge financing for the target, which paused development of its lead fungal infection candidate in April 2026. Biosergen is launching a concurrent SEK 39.9 million rights issue at SEK 0.50 per share. The transaction is highly likely to proceed as 69.6% of Biosergen shareholders and Flerie’s principal shareholder (Thomas Eldered) have provided voting undertakings ahead of an expected merger document in August 2026.

A Swedish commercial property firm (WIHL.ST) agreed to acquire a regional portfolio from Castellum for an underlying property value of SEK 13.3 billion in a transformative consolidation of its core markets. Wihlborgs Fastigheter AB, which focuses on commercial real estate in the Öresund region, will take over 95 properties totaling 635,000 square meters in Malmö, Lund, and Helsingborg. The buyer has secured debt financing from Danske Bank, SEB, and Swedbank, which is expected to result in an initial loan-to-value ratio of 59%. Closing is scheduled for October 1, 2026, contingent on regulatory approval from the Swedish Competition Authority and the Inspectorate of Strategic Products. The acquisition carries an initial yield of 5.0% and offers significant upside potential through the improvement of the portfolio's current 15% vacancy rate.

An industrial group, Sandvik AB (SAND.ST), signed a definitive agreement to acquire Diemme Filtration to expand its downstream mining value chain into a SEK 20 billion addressable market. Sandvik, which provides solutions for manufacturing, mining, and infrastructure, will integrate the high-performance filter press supplier into its newly formed Filtration division. Diemme Filtration is based in Italy, has approximately 200 employees, and expected 2026 revenues of SEK 1.1 billion. The parties did not disclose the purchase price for the transaction, which is expected to close in the third quarter of 2026. The acquisition is expected to be EPS accretive, excluding purchase price allocations, with an EBITA margin that will positively impact the Rock Processing business area.

A biometric identification software provider (Precise Biometrics (PREC.ST)) resolved a directed issue of up to 1.92 billion substitute warrants to Fingerprint Cards AB holders to advance a statutory merger expected to close in early Q3 2026. Warrant holders may elect a 1:1 exchange for the substitute warrants or receive SEK 0.001008 cash per warrant, representing a 12 percent premium to the pre-announcement price. Every 222 substitute warrants grant the right to subscribe for one new Precise Biometrics share at 70 percent of the 10-day VWAP, capped at SEK 3.33, between September 11 and October 2, 2026. The issuance removes the final structural obstacle to closing the merger and implies a maximum dilution of approximately 8.6 million shares, with the subscription cap acting as a valuation ceiling if the combined entity re-rates post-closing.

Medicover (MCOVB.ST) agreed to sell its 66.1% stake in Medicover Hospitals India to KKR for an enterprise value of €1.2 billion. The cash transaction will provide Medicover gross proceeds of €740 million. The target generated LTM revenue of €220.5 million as of June 30, 2026. The deal is expected to close in Q4 2026. This divestiture at roughly 5.4x LTM revenue unlocks significant cash proceeds and provides a catalyst for capital redeployment or return. The sale remains subject to necessary regulatory approvals.

A strategic buyer (Maelir AB) will acquire the European automotive contract manufacturing operations of Bulten AB (BULTEN.ST), a global manufacturer and distributor of fasteners, for an enterprise value of approximately 44.5 MEUR (484 MSEK). Bulten expects total consideration of approximately 273 MSEK, including a 232 MSEK 3-month secured vendor note. The transaction reduces Bulten's annual net sales by approximately 38% and is expected to close by October 2026. This divestment completes the company's exit from global automotive contract manufacturing and triggers a write-down of approximately 1,060 MSEK. Key monitors are the cash conversion of the vendor note and the 24-month brand transition period.

Qben Infra AB (QBEN.ST), a Sweden-listed Nordic infrastructure group, signed a letter of intent to sell its Norwegian Team Bygg construction and real-estate operations for estimated consideration of NOK 50 million. The indicative consideration comprises NOK 10 million in cash at closing and up to NOK 40 million through a 24-month profit-sharing arrangement. Qben intends to focus on Qben Power and its critical-infrastructure and technical-contracting operations. Closing is expected in the third quarter of 2026, subject to due diligence and definitive documentation.

A Swedish property buyer (Wihlborgs Fastigheter) agreed to acquire a $1.4 billion portfolio from Castellum (CAST.ST), a Nordic owner of office, retail, and warehouse properties, in a major capital-recycling event. The definitive agreement covers 95 properties totaling 635,000 square metres across Malmö, Lund, Helsingborg, Ängelholm, and Burlöv for a total consideration of SEK 13.3 billion (~$1.4B). While an expected closing date was not disclosed, the transaction is described as one of the largest property deals in the Swedish market in recent years. This divestment matters as a significant catalyst to reshape the company's geographic exposure through a large-scale capital-recycling initiative.

A Swedish renewable energy firm is divesting its Nordic operating platform to Cloudberry Clean Energy ASA for a 27.01% equity stake and approximately MEUR 97 in cash and debt relief, transforming Orrön Energy AB (ORRON.ST) into a holding company. The seller, a Swedish-listed renewable energy company with Nordic wind assets, will become the largest shareholder in the enlarged Cloudberry while retaining its Karskruv wind farm and European development pipeline. Cloudberry will settle or assume MEUR 93 in loan balances and accrued interest as of year-end 2025 and pay MEUR 4.2 in cash to Orrön. The transaction is conditional on FDI clearance and approval at a Cloudberry EGM no later than 7 August 2026, where shareholders holding 47% of the company have already provided irrevocable voting undertakings. Completion is expected in the second half of 2026. This divestiture makes the concentrated Cloudberry stake Orrön's dominant asset, leaving NAV driven by the stake's post-close trading liquidity and discount dynamics.

KKR is in talks to acquire a 66.9% stake in the Indian hospital arm of Medicover AB (MCOV-B.ST), a Stockholm-listed healthcare and diagnostic services provider, for at least $1.05 billion. The transaction would divest over half of Medicover's hospital footprint, covering 26 multi-specialty hospitals with approximately 6,000 beds and $234.6 million of 2025 revenue. Although a non-binding agreement has been reached, Medicover is running a dual-track process and preparing an IPO for the unit as an alternative. Rothschild is advising Medicover, with Kotak advising the buyer. The proposed price implies a roughly $1.6 billion enterprise value for the Indian unit, giving investors a benchmark as the company weighs a direct sale against a public listing.

The global climate-control technology leader Munters Group AB (MTRS.ST) is exploring a divestiture of its SEK 1,753 million revenue FoodTech business unit to pivot toward its faster-growing data center and air treatment segments. The FoodTech unit, which provides digital solutions for the global food production value chain, generated an adjusted EBITA of SEK 297 million in 2025 at a 17% margin. These results represent 12% of total group sales and 16% of adjusted EBITA, with the business currently operating under the Speria brand. Evercore has been mandated as financial advisor for the potential carve-out of the unit, which is described as a standalone entity with limited synergies to the rest of the group. The formal engagement of a bulge-bracket advisor for this high-margin segment signals a credible process likely to attract both strategic and sponsor interest.

Vestum AB (VESTUM.ST) signed a definitive agreement to sell 100% of Flowa Technology AB to Nordic Capital for an enterprise value of SEK6.5B (~US$689M) on a cash- and debt-free basis. The divested assets comprise 10 water-infrastructure companies with LTM pro forma net sales of SEK1.43B and adjusted EBITA of SEK319M. Expected to close in H2 2026, the transaction is projected to generate a capital gain of approximately SEK3.5B and support a proposed SEK13.50 per share extraordinary dividend, while Vestum intends to use SEK1.45B of proceeds to reduce debt. Based on SEK319M of adjusted EBITA, the SEK6.5B price implies about 20.4x LTM adjusted EBITA.

Nasdaq Stockholm AB is forcing the delisting of 2cureX AB (2CUREX.ST) from the Nasdaq First North Growth Market, removing the primary trading venue for the shares.

Tabellae BidCo ApS is taking Lasernet Group AB (LASER.ST) private following a public offer that gave the buyer 92% of shares and votes. The board has applied to delist the shares from Nasdaq Stockholm, and the last trading day will be announced upon exchange confirmation. An extraordinary general meeting is scheduled for August 31, 2026, to elect a new board. Tabellae BidCo intends to initiate compulsory redemption of all remaining shares. This application signals the end of trading liquidity, and the last trading day will serve as the final exit window for minority shareholders facing compulsory redemption under Swedish law.

Nilörngruppen (NILORN) will be delisted from Nasdaq Stockholm following the approval of its application. The last day of trading is 10 August 2026. Trimco Group (UK) Limited owns over 90 percent of the shares and votes in Nilörngruppen. This event removes the public listing catalyst.

Magle Chemoswed Holding AB (MAGLE.ST) proposes a voluntary delisting from the Nasdaq First North Growth Market conditional on shareholder approval. The board's proposal follows a debt restructuring involving a debt-for-equity swap, super senior bonds, and directed share issues. Shareholders representing approximately 89.67% of shares and votes have indicated they will vote in favor at the August 26, 2026, EGM. If approved, the earliest delisting application date is October 28, 2026, with trading expected to end in November 2026. Under Swedish ASK rules, voluntary delisting requires 90% approval of votes cast and shares represented, making the remaining minority vote critical as current support sits just below that threshold.

Cint Group AB (CINT.ST) is delisting from Nasdaq Stockholm following a takeover by TriCarbs BidCo AB. The buyer owns more than 90% of all shares following its public offer. Nasdaq Stockholm approved the delisting application, and the last day of trading is 7 August 2026. Remaining minority holders must trade on-exchange by this date before the stock goes dark and the bidder proceeds with a compulsory squeeze-out.

Teneo AI AB (TENEO.ST) agreed to convert its approximately SEK 290M (~$30M) senior loan into equity to eliminate all interest-bearing debt to lender Capital Four. Post-refinancing, Capital Four will hold a 29.9% stake in the company. The restructuring is conditional on an EGM approval by 30 September 2026 and a rights issue raising at least SEK 75M (~$7.9M) in gross proceeds to finance operations. A SEK 25M (~$2.6M) subordinated loan will also be converted into shares at up to 2.5x the rights issue price, while the lender receives a SEK 10M (~$1.1M) cash payment and a SEK 25M (~$2.6M) profit-sharing right on a future sale. The debt-for-equity swap removes the senior debt overhang and places Capital Four just below the Swedish mandatory bid threshold, leaving the SEK 75M (~$7.9M) rights issue as the gating condition for dilution.

Magle Chemoswed Holding AB (MAGLE.ST) agreed key restructuring terms with bondholders representing about 79% of its outstanding senior secured bonds. The package includes a partial debt-for-equity swap, up to approximately SEK 203 million of super senior bonds and investor share issues at SEK 1.00 per share. Of the SEK 50.83 million Investor Share Issues, SEK 31.98 million, or 31,980,350 shares, is a set-off of loans owed to PRS1 ApS and MB Holding Koge ApS, SEK 7.5 million is a cash issue to PRS1, and SEK 11.35 million is a cash issue to current and former directors. Additional Bondholder Shares will be issued for the bond write-down and fees. If all issues complete, up to 125,085,215 new shares would be issued, implying approximately 80.5% dilution. An EGM is planned for August 26, 2026, with bondholder, takeover-waiver and FDI approvals also required.

A distressed travel platform operator, Taptravel Nordic AB (TAPTRV.ST), secured bridge financing to address acute liquidity problems after missing a July 3, 2026, interest payment on its Super Senior Bonds. The company obtained a SEK 10 million (~$1M) advance from a major shareholder and a SEK 1.3 million (~$134.6K) bridge loan from representatives and indirect shareholders. Taptravel plans a new share issue for the second half of August 2026, with the advance intended to be set-off against shares. The company acknowledged outstanding events of default under its bonds and will review amending bond terms during August. Its subsidiary, BIG Travel, faces ongoing court proceedings with creditors and has debts registered with the Swedish Enforcement Authority. Bondholders are on watch for potential restructuring or enforcement following the missed payment and planned August bond term review.

Bootstrap Europe IV SCSp converted the full $12 million secured convertible loan into 22,847,044 new ordinary shares of Sivers Semiconductors (SIVE.ST) on July 3, 2026, diluting existing holders by approximately 6.4%. The loan was part of the $17 million facility agreed in February 2026. Separately, Sivers' June 30 directed issue of 12,280,701 shares raised approximately SEK700 million before costs. The conversion removes the $12 million liability, while the placement funds expansion of indium-phosphide laser and optical-amplifier capacity amid a sharp share-price decline, short-seller allegations, and the auditor's going-concern emphasis. Sivers updated its calendar on July 9: the Q2 2026 interim report is due August 27, not August 6.

Elteo Invest AB withdrew its bankruptcy petition against ORTELIUS International AB (ORTIN.ST) after the parties settled a SEK 2.9M bridge-loan dispute. Under the settlement, ORTELIUS will repay SEK 2.4M in cash installments through August 2026 and convert the remaining SEK 500,000 into equity through a directed issue of 2,777,777 shares at SEK 0.18 per share. The settlement removes the immediate bankruptcy-petition risk and partly reduces debt through conversion, but it still creates near-term liquidity demands from the scheduled cash repayments.

Stillfront Group (SF.ST) is continuing a strategic review and CEO succession process following Q2 2026 earnings. The company completed divestments of Narrative and OFM Studios to simplify the group. Q2 2026 net revenue was SEK 1,323 million (~$136M), reflecting a -1.3% organic year-on-year decline, while adjusted EBITDA/EBITDAC margin rose to 29%. The strategic review and CEO succession remain the primary special-situation overhang, though the report provided no new timeline, scope, or advisor details.

Fagerhult Group AB (FAG.ST) is conducting a strategic review to restore margins and improve profitability. Priorities focus on cost reductions, efficiency improvements, and a stronger emphasis on Europe. Q2 2026 order intake rose 8.6% year-over-year to SEK 2.068 billion (~$213M), though the 5.7% EBITA margin before IAC remained below management targets. The board-initiated process may lead to asset sales, portfolio rationalization, or a broader corporate action.

Humble Group AB (HUMBLE.ST) is continuing a strategic review focused on portfolio reshaping through divestments and bolt-on acquisitions. Acting CEO Noel Abdayem stated the review is progressing at a high pace, coinciding with the July 14, 2026, sale of the Fancystage unit for EUR 5 million (~$5.7M). The company reported a SEK 600m (~$62M) impairment of goodwill and intangible assets in the Sustainable Care business area, contributing to a Q2 2026 net loss of SEK -573m on SEK 2,004m (~$208M) in net revenue. The strategic review remains the primary special-situation vector, though no advisor or formal timeline is disclosed.

eEducation Albert AB (publ) (ALBERT.ST), a provider of curriculum-aligned adaptive digital learning platforms, has launched a strategic review of a non-core subsidiary to explore a potential divestment and refocus on core mathematics operations. The company engaged Polar Advisory to evaluate alternatives for the unit, described as a profitable, cash-generating business that is not part of the group's core strategy. The review begins immediately, though the company stated there is no certainty it will result in a transaction and no timeline or valuation guidance was provided. This opens the possibility of a divestiture of a profitable, non-core subsidiary to surface value and refocus on higher-growth mathematics and AI edtech operations.

The board of Teneo AI AB (TENEO.ST), a provider of enterprise Agentic AI solutions for contact center automation, is evaluating a rights issue and an accelerated sale process as the company faces a one-month cash runway. Financial advisor JP Morgan is exploring a sale of all or parts of the business while the company renegotiates a SEK 250m PIK loan with lender CapitalFour. Revenue has been adversely impacted by a legal dispute with a former US reseller, forcing the board to utilize its 17 June 2026 AGM authorization to seek immediate financing. The company must address its liquidity before a SEK 10m minimum liquidity covenant on the PIK loan becomes effective on 31 August 2026. This strategic review is now a forced process where a rights issue remains the likely path to preserve the option value of the company’s AI platform, though failure to secure financing risks a distressed outcome that could wipe out equity.

Riesling Ventures AB launched a public takeover offer for Viva Wine Group AB (VIVA.ST) at SEK 38.5 in cash per share.

Candle Lake Ltd. set a cash offer at SEK695 ($73) per share for Evolution.

A consortium (HealthCo Oy) launched a cash tender offer for Aino Health (AINO.ST), a provider of corporate health management SaaS solutions, at a 56.25% premium to effect a take-private acquisition. The bidder already controls 48.27% of the outstanding shares and is offering SEK 0.20 per share, valuing the total equity at approximately SEK 40.9 million (~$4M). Aino Health’s independent bid committee has unanimously recommended the offer, with an acceptance period scheduled to run from July 1, 2026, through August 10, 2026. Completion is conditional on the bidder reaching an ownership threshold of more than 90% to facilitate a squeeze-out. Shareholders who do not participate risk being left in an illiquid stub if the 90% acceptance level is not met.

The controlling shareholder group (Riesling Ventures AB) is offering to buy out the remaining float of Viva Wine Group AB (publ) (VIVA.ST), a Swedish wine and spirits group, for SEK 38.5 per share in cash. The $358 million offer represents a 38% premium, and the company’s independent bid committee published its recommendation for shareholders to accept the deal today. The consortium, which includes Emil Sallnäs, Björn Wittmark, and John Wistedt, currently holds a 62.79% controlling stake. The offer price has been declared final, meaning no further increases are permitted under takeover rules. Minority shareholders face a binary outcome as failing to reach the 90% threshold for a compulsory squeeze-out would leave remaining investors in an illiquid, controlled listed entity.

Catena Media plc (CTM.ST) launched a voluntary tender offer to repurchase its hybrid capital securities at a deep discount to nominal value.

Boozt AB (BOOZT.ST) expanded its share buyback framework to 300 million kronor from 200 million kronor to continue capital returns.

Catena Media intends to launch a voluntary tender offer for its outstanding capital securities.

Corem Property Group AB (CORE-A.ST) completed the cancellation of 94,021,637 Class B ordinary shares, 106,234 Class D ordinary shares and 122,139 preference shares after the July 2, 2026 extraordinary general meeting; registration occurred on July 3. The approximately 94.25 million-share cancellation reduced registered shares by about 6.9% to 1,273,568,990. Corem subsequently held 21,700,007 Class B shares, 38,633 Class D shares and 39,253 preference shares in treasury, equal to 1.70999% of total shares and 1.04427% of voting rights, causing its treasury holding to cross below the 5% flagging threshold.

Heliospectra AB (HELIO.ST) announced on July 27, 2026 that its board resolved to submit a bankruptcy application to the Gothenburg District Court after failing to secure financing and concluding it could not meet payment obligations or continue operations. The source says the court's decision on the petition is pending; it does not yet report a bankruptcy order or trustee appointment. The failed financing search creates substantial equity-recovery risk, but the filing alone does not establish a zero-recovery outcome.

A Swedish district court granted a three-month extension to the court-supervised reorganization of Scandinavian Enviro Systems AB (SES.ST), a developer of tire-pyrolysis recovery technology, to finalize financing and a 25% creditor recovery plan. The extension moves the reorganization deadline to August 27, 2026, allowing administrator Johan Sölveland at Ackordscentralen to complete negotiations for long-term financing and finalize the restructuring proposal. A formal plan is expected in August 2026 and will include a debt write-down offering non-priority creditors at least 25% of their claims. This Swedish process (företagsrekonstruktion) is analogous to a US Chapter 11 filing, and the August 2026 plan presentation serves as the next concrete milestone for the recovery baseline.

Evolution AB (EVO.ST) terminated its merger agreement to acquire Galaxy Gaming, Inc. Evolution must pay Galaxy Gaming a termination fee of USD 5,234,678. The companies will continue their existing commercial relationship. This termination removes a pending M&A catalyst for Evolution.

The Board of Qben Infra AB (QBEN.ST), a developer of Nordic energy infrastructure, terminated the sale process for its Nordic Inspekt Group subsidiary on June 30, 2026, removing a potential near-term divestiture catalyst. This decision followed a strategic reassessment driven by the subsidiary's improved profitability, strong operational performance, and increased activity levels in recent months. Nordic Inspekt Group will remain an independent business within the portfolio to pursue identified value creation opportunities. The termination signals that the Board values the asset more highly than the bids received, shifting the investment focus back to organic growth and operational execution.

A Swedish investment organization, Athanase Innovation AB (ATIN.ST), will spin off its subsidiary Palvora AB via a 1:1 dividend-in-kind distribution to shareholders. Athanase Innovation, which focuses on private and public innovation companies, will distribute all shares of the subsidiary with a record date of July 13, 2026. The last day to trade Athanase shares with entitlement is July 9, 2026, followed by the distribution payment on July 15, 2026. This Swedish lex ASEA spin-off features a tight timetable and a 1:1 ratio that creates a short window for investors to position for the entitlement.

The board of the Swedish investment organization Athanase Innovation AB (ATIN.ST) proposed a 1:1 in-specie distribution of its stake in Palvora AB to create a tradable stub with a book value of SEK 481 million. Palvora holds approximately 98% of Ivisys AB, and both entities are intended to operate in an unlisted environment following the distribution. An extraordinary general meeting is scheduled for July 3, 2026, to approve the proposal, with an information brochure expected to be published around June 18. The transaction qualifies under the Lex Asea tax ruling, meaning Swedish shareholders receive the Palvora shares without immediate taxation. This creates a mechanical overhang for modeling as the Swedish Tax Agency will determine the cost-basis split between Athanase and Palvora shares post-distribution.

Trimco Group (UK) Limited is taking Nilörngruppen AB (publ) (NILB.ST) private after acquiring over 90% of shares and votes. Trimco declared its public offer unconditional on 13 July 2026 and has requested compulsory redemption of all remaining shares. The Nilörngruppen board has resolved to apply for delisting from Nasdaq Stockholm and scheduled an extraordinary general meeting for 18 August 2026 to elect board members. Trimco's stake triggers a compulsory squeeze-out under the Swedish Companies Act to remove minority shareholders.

Intrum AB (publ) (INTRUM.ST) resolved a second directed issue of up to 204,490,361 shares at SEK 2.45 per share, raising approximately SEK 500 million. Kistefos AS subscribed for this tranche, which completes the two-part, approximately SEK 1.5 billion directed issue within the SEK 7.5 billion recapitalization announced on 7 May 2026. The separate approximately SEK 6 billion rights issue, also priced at SEK 2.45 per share, had already closed on 29 June and was reported fully subscribed on 1 July; subscriptions with rights plus applications without rights equaled approximately 139.2% of the offer. The rights issue is therefore completed, not a forthcoming actionable leg.